Back
Zealand Pharma AS Quote, Financials, Valuation and Earnings
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
70
ZLDPF
Zealand Pharma AS
Last Price:
133.41
Seasonality Move:
9.95%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Zealand Pharma AS Price Quote
$133.41
0.00 (-0.97%)
(Updated: September 19, 2024 at 6:50 AM ET)
Zealand Pharma AS Key Stats
Buy
70
Zealand Pharma AS (ZLDPF)
is a Buy
Day range:
$133.41 - $133.41
52-week range:
$40.40 - $141.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
151.10
P/B ratio:
7.02%
Volume:
145
Avg. volume:
702
1-year change:
219.76%
Market cap:
$9.5B
Revenue:
$49.8M
EPS:
$-1.7
How Much Does Zealand Pharma AS Make?
-
How Much Are Zealand Pharma AS's Sales Annually?
ZLDPF Revenues are $49.8M -
How Much Profit Does Zealand Pharma AS's Make A Year?
ZLDPF net income is -$102.2M
Is Zealand Pharma AS Growing As A Company?
-
What Is Zealand Pharma AS's Growth Rate Quarterly?
Quarterly YoY revenue growth is 2.24% -
What Is Zealand Pharma AS's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Zealand Pharma AS Stock Price Performance
-
Did Zealand Pharma AS Stock Go Up Last Month?
Zealand Pharma AS share price went down by -5.88% last month -
Did ZLDPF's Share Price Rise Over The Last Year?
ZLDPF share price rose by 219.76% over the past 1 year
What Is Zealand Pharma AS 52-Week High & Low?
-
What Is Zealand Pharma AS’s 52-Week High Share Price?
Zealand Pharma AS has traded as high as $141.74 over the past 52 weeks -
What Is Zealand Pharma AS’s 52-Week Low Share Price?
Zealand Pharma AS has traded as low as $40.40 over the past 52 weeks
Zealand Pharma AS Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Zealand Pharma AS?
-
How Much Debt Does Zealand Pharma AS Have?
Total long term debt quarterly is $39.7M -
How Much Cash Does Zealand Pharma AS Have?
Cash and short term investments quarterly total is $1.3B -
What Is Zealand Pharma AS’s Book Value Per Share?
Book value per share is 19.02
Is Zealand Pharma AS Cash Flow Positive?
-
What Is ZLDPF Cash Flow From Operations?
Cash flow from operations (TTM) is -$73M -
What Is Zealand Pharma AS’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.2B -
What Is Zealand Pharma AS’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$177.9M
Zealand Pharma AS Return On Invested Capital
-
Is Management Doing A Good Job?
ZLDPF return on invested capital is -19.92% -
What Is Zealand Pharma AS Return On Assets?
ROA measures how assets are converting to revenues and is -17.89% -
What Is ZLDPF Return On Equity?
ROE is a measure of profitability and is -20.55%
Zealand Pharma AS Earnings Date & Stock Price
-
What Is Zealand Pharma AS's Stock Price Today?
A single share of ZLDPF can be purchased today for 133.41 -
What Is Zealand Pharma AS’s Stock Symbol?
Zealand Pharma AS trades on the otcm under the ticker symbol: ZLDPF -
When Is Zealand Pharma AS’s Next Earnings Date?
The next quarterly earnings date for Zealand Pharma AS is scheduled on November 7, 2024 -
When Is ZLDPF's next ex-dividend date?
Zealand Pharma AS's next ex-dividend date is September 19, 2024 -
How To Buy Zealand Pharma AS Stock?
You can buy Zealand Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Zealand Pharma AS Competitors
-
Who Are Zealand Pharma AS's Competitors?
Below is a list of companies who compete with Zealand Pharma AS or are related in some way:
Zealand Pharma AS Dividend Yield
-
What Is ZLDPF Dividend Yield?
Zealand Pharma AS’s dividend yield currently is 0% -
What Is Zealand Pharma AS’s Payout Ratio?
Zealand Pharma AS’s payout ratio is 0% -
When Did Zealand Pharma AS Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Zealand Pharma AS’s Dividend Per Share?
Zealand Pharma AS pays a dividend of $0.00 per share
Zealand Pharma AS Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 223.9% | 277.75% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 22.50 |
| Downside from Last Price: | -83.14% |